The Medicines and Healthcare products Regulatory Agency (MHRA) has estimated that implementing the Falsified Medicines Directive (FMD) in the UK could cost almost half a billion pounds to implement over the next ten years, depending on how the directive is introduced.

This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the ‘safety features’ provisions of the Falsified Medicines Directive (FMD).

This consultation closes at:
3pm on 23 September 2018

Click here to view full article.